← Back to Search

Other

PQQ supplement for Maternal Obesity (EPyQ Trial)

Q: Is the enrollment phase of this medical study currently accepting participants?

According to details available on clinicaltrials.gov, the current trial is not in a recruitment phase. Initially listed on 2/22/2024 and last updated on 2/5/2024, this study has concluded its search for participants. Nonetheless, there are currently five alternative studies seeking eligible patients.

Q: Who is the ideal candidate to participate in this medical research study?

To participate in this medical study, volunteers must have maternal <a href="https://www.withpower.com/clinical-trials/obesity">obesity</a> and be between 18 and 40 years old. The trial is accepting a total of 30 participants.

Q: Are individuals who are 85 years old or older included in this research study?

Eligible participants for this research must fall between the ages of 18 and 40. Separate trials are available for individuals under 18 years old as well as those above 65, with a total of two and three studies respectively.

Phase < 1

Waitlist Available

Led By Marty Maxted, MD

Research Sponsored by University of Oklahoma

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 month postpartum

Awards & highlights

EPyQ Trial Summary

This trial aims to study the effects of a natural food supplement called Pyrroloquinoline quinone (PQQ) on pregnant women who are obese. The researchers believe that PQQ may

Who is the study for?

This trial is for pregnant women dealing with obesity. It aims to explore a non-drug approach to reduce inflammation and improve metabolism during pregnancy, which may benefit both the mother's health and the child's development.Check my eligibility

What is being tested?

Researchers are testing Pyrroloquinoline Quinone (PQQ), a natural supplement thought to have anti-inflammatory effects, against a placebo containing soybean oil. The goal is to see if PQQ can positively impact maternal health and reduce baby fat levels.See study design

What are the potential side effects?

Since PQQ is a dietary supplement, it might be well-tolerated with minimal side effects; however, potential risks could include allergic reactions or gastrointestinal discomfort.

EPyQ Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 month postpartum

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 month postpartum

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month postpartum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adiponectin

C-reactive protein (CRP)

Glucose

+17 more

EPyQ Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: PQQ supplementActive Control1 Intervention

Pyrroloquinoline quinone (PQQ) 20 mg/day

Group II: PlaceboPlacebo Group1 Intervention

Placebo supplement with soybean oil 20 mg/day

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor

455 Previous Clinical Trials

97,580 Total Patients Enrolled

Marty Maxted, MDPrincipal InvestigatorUniversity of Oklahoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment phase of this medical study currently accepting participants?

"According to details available on clinicaltrials.gov, the current trial is not in a recruitment phase. Initially listed on 2/22/2024 and last updated on 2/5/2024, this study has concluded its search for participants. Nonetheless, there are currently five alternative studies seeking eligible patients."

Answered by AI

Who is the ideal candidate to participate in this medical research study?

"To participate in this medical study, volunteers must have maternal obesity and be between 18 and 40 years old. The trial is accepting a total of 30 participants."

Answered by AI

Are individuals who are 85 years old or older included in this research study?

"Eligible participants for this research must fall between the ages of 18 and 40. Separate trials are available for individuals under 18 years old as well as those above 65, with a total of two and three studies respectively."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluating Pyrroloquinoline Quinone (PQQ) for Improving Obese Pregnancy Outcomes

2024. "Evaluating Pyrroloquinoline Quinone (PQQ) for Improving Obese Pregnancy Outcomes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06245083.